BIG
GSK icon

Brooklyn Investment Group’s GSK GSK Stock Holding History

Brooklyn Investment Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71M Buy
121,594
+28,709
+31% +$1.56M 0.21% 70
2025
Q4 		$4.56M Buy
92,885
+65,457
+239% +$3.05M 0.21% 79
2025
Q3 		$1.06M Buy
27,428
+282
+1% +$11K 0.14% 146
2025
Q2 		$1.04M Buy
27,146
+13,521
+99% +$517K 0.14% 154
2025
Q1 		$528K Buy
13,625
+13,013
+2,126% +$476K 0.11% 170
2024
Q4 		$20.7K Buy
+612
New +$22K 0.01% 744

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Brooklyn Investment Group's GSK Position: Q1 2026 in Review

Brooklyn Investment Group increased its GSK (GSK) stake by 31% in Q1 2026, buying an estimated $1.56M and bringing the position to 121,594 shares worth $6.71M. The position accounts for 0.21% of the portfolio, ranked #70.

Brooklyn Investment Group first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Brooklyn Investment Group held 121,594 shares of GSK worth $6.71M as of Q1 2026.
  • Brooklyn Investment Group bought 28,709 GSK shares in Q1 2026, an estimated $1.56M.
  • GSK made up 0.21% of Brooklyn Investment Group's portfolio in Q1 2026, its #70 holding.
  • Brooklyn Investment Group first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.